Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human NKCC1 ELISA Kit (AC3663)
Cat.#: ASET-2252
Specifications
Description Human NKCC1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NKCC1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 11.49 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1917 Human Leptin ELISA Kit (AC3328) Quantitative inquiry ASET-1616 Human 5HT2A Receptor ELISA Kit (AC3027) Quantitative inquiry ASET-1043 Mouse Glypican 4 ELISA Kit (AC2454) Quantitative inquiry ASET-2416 Human SRD5A1 ELISA Kit (AC3827) Quantitative inquiry ASET-1948 Mouse IRS1 ELISA Kit (AC3359) Quantitative inquiry ASET-1093 Human TrkB ELISA Kit (AC2504) Quantitative inquiry ASET-2243 Human Dopamine Receptor D1 ELISA Kit (AC3654) Quantitative inquiry ASET-1303 Mouse Neurotrophin 3 ELISA Kit (AC2714) Quantitative inquiry ASET-1614 Human TDP43 ELISA Kit (AC3025) Quantitative inquiry ASET-2224 Human Apelin ELISA Kit (AC3635) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket